“2030 cord blood banking services market value to reach USD 41.36 billion”
The global cord blood banking services market size was valued at USD 25.47 billion in 2023 and is projected to grow at a CAGR of 7.4% from 2024 to 2030. The cord blood banking market is expected to experience significant changes owing to advancements in technology and increased awareness of the healing capabilities of cord blood stem cells. As personalized medicine gains more attention, there is a noticeable surge in the request for private cord blood banking services, enabling families to preserve a valuable biological asset for potential future medical interventions.
The increasing awareness of the benefits of cord blood containing stem cells is a significant factor fueling the growth of the cord blood banking service market. The rise in research and development activities in the biotechnology sector, coupled with the expanding applications of cord blood and stem cells in genetic disease treatment for curing various chronic diseases, is driving market growth. The widespread availability of service providers globally and the growing focus of federal agencies on establishing public banking units are additional factors influencing the market.
In addition, improved healthcare facilities, urban development, digitalization, increased awareness, and research and development, contribute to the growth of the cord blood banking service market. Moreover, the increasing prevalence of genetic disorders and advancements in biotechnology offer lucrative prospects for market participants.
In 2023, the processing segment dominated the market, attributed to the clinical trials, increasing research on cord blood and a rising incidence of hematological disorders contributing to the industry growth.
The storage segment is expected to witness a significant growth over the forecast period, owing to the increase in awareness among parents and the rising demand for storage of blood cord in public and private cord blood bank by parents to donate their newborn babies’ cord to hospitals for further use.
The cord blood segment dominated the market in 2023, owing to the rising awareness and adoption of stem cell therapies for a range of medical illness, including hematological disorders, immune system disorders and various type of cancer.
The cord tissue segment is expected to witness a significant growth over the forecast period. The growth is mainly driven by increasing awareness and interest of regenerative medicines and the potential of mesenchymal stem cells (MSC). Moreover, technological advancements and ongoing research in processing and storage techniques for cord tissue contribute to the expansion in cord blood banking services market.
Cancer dominated the market and accounted for largest share in 2023. Cord blood stems cells transplant has been proven effective in treating various diseases like leukemia, lymphoma and other chronic diseases which is anticipated to drive growth. Moreover, the rise in the prevalence of cancer is fueling the cord blood banking services market.
Blood disorder is expected to witness the fastest CAGR over the forecast period. With the increasing prevalence of blood-related disorders such as e leukemia, sickle cell anemia, and thalassemia, blood disorders have emerged as a significant segment in the cord blood banking services market.
Hospitals dominated the market in 2023. The major key drivers are the increasing awareness of the importance of cord blood banking, rising disposable income and the infrastructural & technological developments of hospitals. The use of cord blood for treating life threatening diseases such as blood cancer and blood disorder has contributed to the growth of hospitals market share in the past.
Research institutes are expected to witness the fastest CAGR during the forecast period. Research institutes contribute to the development of innovative stem cell therapies and clinical protocols, providing new opportunities for cord blood banks.
The private segment dominated the market and accounted for the largest market revenue share of 45.5% in 2023. When parents store their baby’s cord blood in private cord blood bank, they pay the charged amount and ongoing storage fees, and it is saved for their use. One of the major factors driving the market is, parents are over charged for the collection and storage of cord blood banks.
The public segment is expected to witness significant growth during the forecast period. The American Academy of Pediatrics recommends parents to donate cord blood banks to public unless a close family member is a potential recipient for cord blood stem cell transplantation.
In 2023, North America cord blood banking services market dominated the global market with a revenue share of 42.5%, owing to the availability of well-developed health infrastructure, rising awareness associated with available services and growing healthcare expenditure of the countries such as the U.S. & Canada. The rise in the prevalence of cancers such as leukemia and lymphomas as contributing to this growth. According to American cancer society, in 2024, about 20,800 people will be diagnosed with leukemia and about 11,220 people may die from leukemia and most of these cases will be in adult.
In 2023, the U.S. cord blood banking services emerged as a frontrunner, capturing a significant market of 9.57 billion, owing to the expanding application of cord blood & stem cells in treating various disease, increasing public awareness regarding the advantages of cord blood banking and a growing number of services providers in market. Furthermore, rising research and development activity by various research institutes present in the country is likely to contribute to the market growth.
The Europe cord blood banking services market held a significant market share in 2023. This growth can be attributed to a rising prevalence of chronic disease such as cancer and diabetes and the presence of well-established network of cord blood banks in the region.
The cord blood banking services market in Germany holds a prominent position in the Europe region. The growth of the cord blood banking industry is being fueled by higher rates of genetic abnormalities, supportive government regulations, increasing disposable income and healthcare expenditure.
The UK cord blood banking services market is expected to grow rapidly in the coming years owing to the presence of key companies in the region and high technological advancements.
The cord blood banking services market in Asia Pacific is projected to witness the fastest CAGR of 9.0% during the forecast period. The growth is driven by growing awareness of stem cell storage and improved healthcare policies in the region. Malaysia, India, Indonesia, and China have shown promising growth prospects for the cord blood banking services market. Efforts such as placing notice boards and charts in numerous hospitals and healthcare centers in these countries have significantly raised awareness on these services.
The China cord blood banking services market held the largest market share in 2023 owing to growing awareness among Chinese parents about the potential of stem cell therapies for various diseases. This is fueled by rising rates of chronic illness like cancer and diabetes. In addition, the presence of established cord blood banks with advanced storage facilities creates a robust infrastructure to support market growth.
India cord blood banking services market is expected to witness the fastest CAGR during the forecast period, owing to the growing disposable income and increasing awareness about the potential of cord blood banking for future medical needs. Furthermore, the rising burden of chronic disease such as cancer and blood disorders in India increases the demand for stem cell therapies.
Some of the key companies in the cord blood banking services market include Global Cord Blood Corporation; CSG-BIO; Cryo-Cell International; California Cryobank Stem Cell Services LLC; CBR Systems Inc.
CBR Systems Inc has led the industry in technical innovations and provided families with access to current treatments and experimental stem cell therapies for conditions that have no cure.
The following are the leading companies in the cord blood banking services market. These companies collectively hold the largest market share and dictate industry trends.
In March 2024, Cryo-Cell announced the spin-off of Celle Corp. (its subsidiary) to maximize shareholder value.
In April 2022, Global Cord Blood Corporation announced that it would acquire Cellenkos, Inc. It was expected to be a 100% acquisition along with the rights to develop & commercialize its future and existing products except for the products related to Cellenkos’s existing collaboration with Incyte Corporation.
Report Attribute |
Details |
Market size value in 2024 |
USD 26.99 billion |
Revenue forecast in 2030 |
USD 41.36 billion |
Growth rate |
CAGR of 7.4% from 2024 to 2030 |
Base year for estimation |
2023 |
Historical data |
2018 - 2022 |
Forecast period |
2024 - 2030 |
Quantitative units |
Revenue in USD billion, and CAGR from 2024 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Service, bank, component, application, end-use region |
Regional scope |
North America, Europe, Asia Pacific, Latin America, MEA |
Country scope |
U.S., Canada, Mexico, UK, Germany, France, Italy, Spain, Denmark, Sweden, Norway, Japan, China, India, Australia, South Korea, Thailand, Brazil, Argentina, South Africa, Saudi Arabia, UAE, Kuwait. |
Key companies profiled |
Global Cord Blood Corporation; CBR Systems Inc.; Cryo-Cell International; Cordlife Group Limited; AlphaCord LLC; CSG-BIO; California Cryobank Stem Cell Services LLC; Cord Blood Foundation (Smart Cells International); Singapore Cord Blood Bank; FamiCord; |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global cord blood banking services market report based on service, bank, component, application, end-use, and region.
Service Outlook (Revenue, USD Billion, 2018 - 2030)
Collection & Transportation
Processing
Analysis
Storage
Bank Outlook (Revenue, USD Billion, 2018 - 2030)
Private
Public
Hybrid
Component Outlook (Revenue, USD Billion, 2018 - 2030)
Cord Blood
Cord Tissue
Application Outlook (Revenue, USD Billion, 2018 - 2030)
Cancer
Genetic Disorders
Blood Disorders
Immune Deficiencies
Metabolic Disorders
Other Applications
End-use Outlook (Revenue, USD Billion, 2018 - 2030)
Hospitals
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Regional Outlook (Revenue, USD Billion, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."